Stock Events

Stock Events

Iterum Therapeutics 

$0.03
79
+$0.02+184% Monday 13:30

Statistics

Day High
0.03
Day Low
0.02
52W High
1.13
52W Low
0.01
Volume
53,098
Avg. Volume
-
Mkt Cap
1.39M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.24
-0.19
-0.14
-0.09
Expected EPS
-0.1
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-49.55MNet Income

Analyst Ratings

0Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ITRM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a major pharmaceutical company that competes with Iterum Therapeutics in the development and marketing of antibiotics and treatments for infections, a key area for Iterum.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including anti-infectives, directly competing with Iterum's product offerings.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline plc focuses on creating vaccines and antibiotics, competing with Iterum Therapeutics in the antibiotics market.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie Inc. operates in the pharmaceuticals sector, including the development of anti-infective therapies, making it a competitor to Iterum Therapeutics.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical segment, develops and sells products in various therapeutic areas, including infectious diseases, competing with Iterum.
Novartis
NVS
Mkt Cap279.67B
Novartis AG is a global healthcare company that has a strong presence in the development of drugs for infectious diseases, competing with Iterum Therapeutics.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca PLC is involved in the discovery and development of antibiotics, directly competing with Iterum Therapeutics in the anti-infective space.
Sanofi
SNY
Mkt Cap110.4B
Sanofi is a global life sciences company that focuses on healthcare solutions, including antibiotics, making it a competitor to Iterum Therapeutics.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries Limited operates in generic and specialty medicines, including the development of anti-infective drugs, competing with Iterum.
Seres Therapeutics
MCRB
Mkt Cap73.3M
Seres Therapeutics, Inc. focuses on microbiome therapeutics for infections and other conditions, representing a novel competition to Iterum Therapeutics in the infectious disease sector.

About

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Show more...
CEO
Mr. Corey N. Fishman
Employees
9
Country
Ireland
ISIN
IE000TTOOBX0

Listings

OTC Link
US
ITRMF
XNAS
US
ITRM
BOATS
BOATS
ITRM.BOATS

0 Comments

Share your thoughts

FAQ

What is Iterum Therapeutics stock price today?▼
The current price of ITRM is $0.03 USD — it has increased by +184% in the past 24 hours. Watch Iterum Therapeutics stock price performance more closely on the chart.
What is Iterum Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Iterum Therapeutics stocks are traded under the ticker ITRM.
Is Iterum Therapeutics stock price growing?▼
ITRM stock has risen by +184% compared to the previous week, the month change is a -5.33% fall, over the last year Iterum Therapeutics has showed a -97.15% decrease.
What is Iterum Therapeutics market cap?▼
Today Iterum Therapeutics has the market capitalization of 1.39M
When is the next Iterum Therapeutics earnings date?▼
Iterum Therapeutics is going to release the next earnings report on May 20, 2026.
What were Iterum Therapeutics earnings last quarter?▼
ITRM earnings for the last quarter are -0.2 USD per share, whereas the estimation was -0.15 USD resulting in a -37.93% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Iterum Therapeutics revenue for the last year?▼
Iterum Therapeutics revenue for the last year amounts to 0 USD.
What is Iterum Therapeutics net income for the last year?▼
ITRM net income for the last year is -49.55M USD.
How many employees does Iterum Therapeutics have?▼
As of May 06, 2026, the company has 9 employees.
In which sector is Iterum Therapeutics located?▼
Iterum Therapeutics operates in the Health & Wellness sector.
When did Iterum Therapeutics complete a stock split?▼
The last stock split for Iterum Therapeutics was on August 18, 2022 with a ratio of 1:15.
Where is Iterum Therapeutics headquartered?▼
Iterum Therapeutics is headquartered in Dublin, Ireland.